Return to PCORI.org 
Partnering Research and Community Organizations for Novel Health Equity Research: Addressing Health Systems Factors and Social Determinants of Maternal Health - 2023 Cycle 1
- Which intervention settings are allowable under this funding announcement?
- What does it mean to be a multisite study?
- Do applicants need to confirm all study sites by the time of Letter of Intent (LOI) submission, including sites in a multisite study?
- Would a pediatric health intervention be considered to meet the setting requirement?
- Is it acceptable to include health systems in one state? The health systems span the state, and the patient populations are heterogenous.
- Which patient populations are eligible for studies/being targeted by this funding announcement?
- Can the population be low income, limited English proficient Asian American communities?
- Which interventions are eligible?
- Does the evidence of efficacy for the comparators require a systematic review?
- Do interventions have to include adaptation/tailoring for specific populations?
- Will PCORI cover any intervention costs in the budget?
- Is "treatment" versus "usual care" considered an appropriate comparator?
- Can one of the components of CER compare a new evidence-based intervention?
- What if your intervention is specificized at different levels (example: the intervention is at the community level and standard of care at the clinic/healthcare level)?
- Which outcomes should be included?
- Would mental health be a sufficient primary outcome?
- Can one component of a composite outcome include infant birth outcomes (e.g., preterm birth (PTB), low birth weight (LBW))?
- Which types of research designs are eligible for this funding announcement?
- What length of follow-up is required?
- Can the follow up be longer than 12 months postpartum?
- Which stakeholders need to be engaged in this study?
- What aspects of the study should include stakeholder engagement?
- Could we have two co-Principal Investigators (PIs) at the research organization and one at the community organization?
- What is the difference between the core partnership and the broader award partnership?
- Would a local community hospital be an appropriate community partner?
- Does a hospital system need to be involved in the research?
- Can a healthcare system—with the primary business line of clinical care—be acknowledged as a community organization even if the health system has research (or academics) as a secondary business line, or are they excluded as community organization?
- Would a state Medicaid program be eligible to partner as a community partner in addition to other community partners?
- Could you clarify whether the previous relationship is between the organizations or the individual PIs?
- Is there a minimum length of time that will be considered as sufficient regarding the "established relationship" between the core partners?